Clinical experience of «Divigel» application

Abstract

The research, carried out by the authors, has shown high clinical efficiency of transdermal estrogen drug «Divigel» in climacteric disturbances treatment.

Keywords

Divigel / transdermal estrogen / menopausal disorders / clinical experience

References

[1] Griffith S.A review of the factors associated with patient compliance and the taking of prescribed medicines. Br. J. Gen. Pract., 1990,40, 114-16

[2] Purdie D.W. Evaluation and management of the HPT candidate. J.Gynecol. Endocrinol, 1998, 12 (Suppl.l) : 12-16

[3] Crook D., The metabolic consequences of treating postmenoipausal women with nonoral hormone replacement therapy, Br.J.Obstet. and Gynec., 1997, Vol. 104, (Suppl. 16), 4-14

[4] Karjalainen A., Heikkinen J., Savolainen M.J., Backstrom A.-C., Salinto M., Kesaniemi Y.A., Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy., Br.J. Obstet Gynecol., 1997, Vol. 104, (Suppl. 16), 38-43

[5] Stampfer M.J., Grodstein F. Role of hormone replacement in cardiovascular disease. In: Treatment of the postmenopausal women: basic and clinical aspects. Lobo R.A., ed. Raven Press Ltd, New York, USA; 1994, 223-233

[6] Jarvinen A., Granander M., Nykanen S., Laine T., Geurts P., Viitanen A. Steady-state pharmacocinetics of oestradiol gel in postmenopausal women: effects of application area and washing, Br.J. Obstet. Gynecol., 1997, Vol. 104, (Suppl. 16), 14-19

RIGHTS & PERMISSIONS

Eсо-Vector